{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:29:34Z","timestamp":1785576574692,"version":"3.56.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002632","name":"Hallym University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study evaluated the association between metabolic health status and incident kidney cancer among obese participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>A total of 514,866 individuals were included from the Korean National Health Insurance Service-National Health Screening Cohort. Changes in metabolic health status and obesity from the baseline examination in 2009\u20132010 to the next biannual examination in 2011\u20132012 were determined. Based on the status change, obese participants were divided into four groups: stable metabolically healthy obesity, metabolically healthy obesity to metabolically unhealthy obesity, metabolically unhealthy obesity to metabolically healthy obesity, and stable metabolically unhealthy obesity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The stable metabolically healthy obesity phenotype did not confer an increased risk of incident kidney cancer, compared to the stable metabolically healthy non-obese group. In contrast, the metabolically healthy obesity to metabolically unhealthy obesity group had a significantly higher risk of incident kidney cancer than the stable metabolically healthy non-obese group. Among patients with metabolically unhealthy obesity at baseline, those who transitioned to the metabolically healthy obese group had no increased risk of kidney cancer, whereas those who remained in metabolically unhealthy obesity status had a higher risk of incident kidney cancer than the stable metabolically healthy non-obese group. The transition or maintenance of metabolic health was a decisive factor for kidney cancer in obese patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Maintaining or restoring metabolic health should be stressed upon in obese patients to reduce the risk of kidney cancer.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.976056","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T08:46:21Z","timestamp":1666255581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Implications of metabolic health status and obesity on the risk of kidney cancer: A nationwide population-based cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Yun Kyung","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwi Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong-Yeol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Je","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Jee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/epirev\/mxm012","article-title":"The global epidemic of obesity: An overview","volume":"29","author":"Caballero","year":"2007","journal-title":"Epidemiol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00462-1","article-title":"Global pandemics interconnected - obesity, impaired metabolic health and covid-19","volume":"17","author":"Stefan","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7570\/jomes21004","article-title":"Nontraditional risk factors for obesity in modern society","volume":"30","author":"Han","year":"2021","journal-title":"J Obes Metab Syndr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012860","article-title":"The association between bmi and kidney cancer risk: An updated dose-response meta-analysis in accordance with prisma guideline","volume":"97","author":"Liu","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.hjr.0000114707.27531.48","article-title":"International obesity task f. the obesity epidemic, metabolic syndrome and future prevention strategies","volume":"11","author":"James","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-013-9252-x","article-title":"Metabolically healthy obesity: Definitions, determinants and clinical implications","volume":"14","author":"Phillips","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/obr.12199","article-title":"Metabolically healthy and unhealthy obese\u2013the 2013 stock conference report","volume":"15","author":"Samocha-Bonet","year":"2014","journal-title":"Obes Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.259","article-title":"Metabolically healthy obesity: A friend or foe","volume":"32","author":"Jung","year":"2017","journal-title":"Korean J Intern Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.055","article-title":"Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk","volume":"71","author":"Mongraw-Chaffin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016640","article-title":"Cohort profile: The national health insurance service-national health screening cohort (Nhis-heals) in Korea","volume":"7","author":"Seong","year":"2017","journal-title":"BMJ Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Consultation","year":"2004","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2011.35.6.561","article-title":"Obesity and metabolic syndrome in Korea","volume":"35","author":"Oh","year":"2011","journal-title":"Diabetes Metab J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7570\/jomes.2019.28.1.40","article-title":"2018 Korean Society for the study of obesity guideline for the management of obesity in Korea","volume":"28","author":"Seo","year":"2019","journal-title":"J Obes Metab Syndr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (Ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel iii)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3607","article-title":"Metabolic health is a determining factor for incident colorectal cancer in the obese population: A nationwide population-based cohort study","volume":"10","author":"Cho","year":"2021","journal-title":"Cancer Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001377","article-title":"A systematic review and meta-analysis of the significance of body mass index on kidney cancer outcomes","volume":"205","author":"Kim","year":"2021","journal-title":"J Urol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2010.03.008","article-title":"Body mass index and subsequent risk of kidney cancer: A prospective cohort study in Japan","volume":"20","author":"Sawada","year":"2010","journal-title":"Ann Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-015-0611-7","article-title":"Association of hypertension and obesity with renal cell carcinoma risk: A report from the shanghai men's and women's health studies","volume":"26","author":"Shen","year":"2015","journal-title":"Cancer Causes Control"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0500-z","article-title":"Obesity, abdominal obesity and subsequent risk of kidney cancer: A cohort study of 23.3 million East asians","volume":"121","author":"Nam","year":"2019","journal-title":"Br J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057475","article-title":"Metabolic factors associated with risk of renal cell carcinoma","volume":"8","author":"Haggstrom","year":"2013","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091329","article-title":"Metabolic syndrome resolved within two years is still a risk factor for kidney cancer","volume":"8","author":"Oh","year":"2019","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.05.002","article-title":"Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: A nationwide population-based cohort study","volume":"97","author":"Cho","year":"2019","journal-title":"Metabolism"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa033","article-title":"Impact of transition in metabolic health and obesity on the incident chronic kidney disease: A nationwide cohort study","volume":"105","author":"Cho","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0449","article-title":"Stability of metabolically healthy obesity over 8 years: The English longitudinal study of ageing","volume":"173","author":"Hamer","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.077","article-title":"The natural course of healthy obesity over 20 years","volume":"65","author":"Bell","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2019.34.4.406","article-title":"Impact of the dynamic change of metabolic health status on the incident type 2 diabetes: A nationwide population-based cohort study","volume":"34","author":"Kim","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4161\/onci.27810","article-title":"Obesity and renal cancer: Role of adipokines in the tumor-immune system conflict","volume":"3","author":"Gati","year":"2014","journal-title":"Oncoimmunology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00065","article-title":"Mechanisms linking excess adiposity and carcinogenesis promotion","volume":"5","author":"Perez-Hernandez","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0135","article-title":"Insulin and igfs in renal cancer risk and progression","volume":"22","author":"Solarek","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12885-016-2437-4","article-title":"Insulin-like growth factor-1 signaling in renal cell carcinoma","volume":"16","author":"Tracz","year":"2016","journal-title":"BMC Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.976056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T08:46:24Z","timestamp":1666255584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.976056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":34,"alternative-id":["10.3389\/fendo.2022.976056"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.976056","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"article-number":"976056"}}